MDGL
Madrigal Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$541.08
−0.28%Leverage
- Debt / equity
- 0.66x
- Net debt / equity
- 0.11x
- Debt / assets
- 0.28x
- Debt / EBITDA
- -1.16x
- Net debt / EBITDA
- -0.18x
Liquidity & coverage
- Current ratio
- 3.20x
- Quick ratio
- 2.94x
- Cash ratio
- 2.24x
- Interest coverage
- -20.64x
- EBITDA / interest
- -19.12x
- Working capital
- $825.0M
Cash & dividend
- FCF / debt
- -0.59x
- Cash flow / debt
- -0.57x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026